Rank | Gene Set | Z-score |
---|---|---|
1 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.98230979 |
2 | alpha-linolenic acid metabolic process (GO:0036109) | 4.58019661 |
3 | L-phenylalanine catabolic process (GO:0006559) | 4.43824391 |
4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.43824391 |
5 | lysine metabolic process (GO:0006553) | 4.35660864 |
6 | lysine catabolic process (GO:0006554) | 4.35660864 |
7 | regulation of triglyceride catabolic process (GO:0010896) | 4.35344715 |
8 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.34100287 |
9 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.19382402 |
10 | L-phenylalanine metabolic process (GO:0006558) | 4.19382402 |
11 | protein carboxylation (GO:0018214) | 4.13706123 |
12 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.13706123 |
13 | regulation of sequestering of triglyceride (GO:0010889) | 4.10067233 |
14 | glyoxylate metabolic process (GO:0046487) | 4.06707840 |
15 | aromatic amino acid family catabolic process (GO:0009074) | 4.01794358 |
16 | urea metabolic process (GO:0019627) | 3.95256211 |
17 | urea cycle (GO:0000050) | 3.95256211 |
18 | plasma lipoprotein particle clearance (GO:0034381) | 3.89636344 |
19 | amino-acid betaine metabolic process (GO:0006577) | 3.87239635 |
20 | kynurenine metabolic process (GO:0070189) | 3.83510406 |
21 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.80935557 |
22 | cysteine metabolic process (GO:0006534) | 3.76739910 |
23 | fatty acid beta-oxidation (GO:0006635) | 3.75798305 |
24 | complement activation, alternative pathway (GO:0006957) | 3.75768481 |
25 | phospholipid efflux (GO:0033700) | 3.73504832 |
26 | high-density lipoprotein particle remodeling (GO:0034375) | 3.72977795 |
27 | fatty acid transmembrane transport (GO:1902001) | 3.71148789 |
28 | sulfur amino acid catabolic process (GO:0000098) | 3.68169308 |
29 | positive regulation of lipid catabolic process (GO:0050996) | 3.67508620 |
30 | plasma lipoprotein particle assembly (GO:0034377) | 3.67097665 |
31 | low-density lipoprotein particle clearance (GO:0034383) | 3.66772107 |
32 | negative regulation of fibrinolysis (GO:0051918) | 3.64471431 |
33 | regulation of cholesterol homeostasis (GO:2000188) | 3.63717824 |
34 | indole-containing compound catabolic process (GO:0042436) | 3.63380210 |
35 | indolalkylamine catabolic process (GO:0046218) | 3.63380210 |
36 | tryptophan catabolic process (GO:0006569) | 3.63380210 |
37 | protein localization to endosome (GO:0036010) | 3.61761888 |
38 | phospholipid homeostasis (GO:0055091) | 3.59641030 |
39 | fatty acid oxidation (GO:0019395) | 3.58422061 |
40 | triglyceride homeostasis (GO:0070328) | 3.57469158 |
41 | acylglycerol homeostasis (GO:0055090) | 3.57469158 |
42 | homocysteine metabolic process (GO:0050667) | 3.56697337 |
43 | protein-lipid complex assembly (GO:0065005) | 3.56115833 |
44 | regulation of protein activation cascade (GO:2000257) | 3.55896521 |
45 | nitrogen cycle metabolic process (GO:0071941) | 3.55821050 |
46 | bile acid biosynthetic process (GO:0006699) | 3.53428608 |
47 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.52861757 |
48 | lipid oxidation (GO:0034440) | 3.52373490 |
49 | plasma lipoprotein particle remodeling (GO:0034369) | 3.46220654 |
50 | protein-lipid complex remodeling (GO:0034368) | 3.46220654 |
51 | macromolecular complex remodeling (GO:0034367) | 3.46220654 |
52 | reverse cholesterol transport (GO:0043691) | 3.45565004 |
53 | tryptophan metabolic process (GO:0006568) | 3.42285631 |
54 | cholesterol efflux (GO:0033344) | 3.41992269 |
55 | carnitine shuttle (GO:0006853) | 3.41359724 |
56 | regulation of cholesterol esterification (GO:0010872) | 3.40983719 |
57 | fatty acid catabolic process (GO:0009062) | 3.40115825 |
58 | carnitine metabolic process (GO:0009437) | 3.39925441 |
59 | regulation of complement activation (GO:0030449) | 3.38668671 |
60 | positive regulation of fatty acid oxidation (GO:0046321) | 3.37961998 |
61 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.36027156 |
62 | 2-oxoglutarate metabolic process (GO:0006103) | 3.31546711 |
63 | acetyl-CoA metabolic process (GO:0006084) | 3.30121275 |
64 | negative regulation of sterol transport (GO:0032372) | 3.29694351 |
65 | negative regulation of cholesterol transport (GO:0032375) | 3.29694351 |
66 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.27789694 |
67 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.27789694 |
68 | short-chain fatty acid metabolic process (GO:0046459) | 3.26731966 |
69 | cellular ketone body metabolic process (GO:0046950) | 3.26364484 |
70 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.25561381 |
71 | regulation of fibrinolysis (GO:0051917) | 3.24155231 |
72 | cholesterol homeostasis (GO:0042632) | 3.22895777 |
73 | sterol homeostasis (GO:0055092) | 3.20485691 |
74 | positive regulation of lipid storage (GO:0010884) | 3.20193610 |
75 | monocarboxylic acid catabolic process (GO:0072329) | 3.15760241 |
76 | barbed-end actin filament capping (GO:0051016) | 3.15228555 |
77 | regulation of fatty acid oxidation (GO:0046320) | 3.15226569 |
78 | drug catabolic process (GO:0042737) | 3.14856098 |
79 | bile acid metabolic process (GO:0008206) | 3.13529607 |
80 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.12338058 |
81 | bile acid and bile salt transport (GO:0015721) | 3.10815706 |
82 | cellular glucuronidation (GO:0052695) | 3.10741808 |
83 | aspartate family amino acid catabolic process (GO:0009068) | 3.10471205 |
84 | ethanol oxidation (GO:0006069) | 3.09872740 |
85 | lipoprotein metabolic process (GO:0042157) | 3.07437687 |
86 | intestinal cholesterol absorption (GO:0030299) | 3.07374061 |
87 | plasma lipoprotein particle organization (GO:0071827) | 3.05774112 |
88 | regulation of cholesterol metabolic process (GO:0090181) | 3.05646791 |
89 | regulation of cholesterol storage (GO:0010885) | 3.05375871 |
90 | serine family amino acid catabolic process (GO:0009071) | 3.04535803 |
91 | flavonoid metabolic process (GO:0009812) | 3.03530559 |
92 | protein-lipid complex subunit organization (GO:0071825) | 3.03353923 |
93 | positive regulation of triglyceride metabolic process (GO:0090208) | 3.03259563 |
94 | epoxygenase P450 pathway (GO:0019373) | 2.99010807 |
95 | NADH metabolic process (GO:0006734) | 2.97310080 |
96 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.94935700 |
97 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.94935700 |
98 | modulation by symbiont of host immune response (GO:0052553) | 2.94935700 |
99 | positive regulation by symbiont of host defense response (GO:0052509) | 2.94935700 |
100 | modulation by symbiont of host defense response (GO:0052031) | 2.94935700 |
101 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.94935700 |
102 | stress fiber assembly (GO:0043149) | 2.94721314 |
103 | hypotonic response (GO:0006971) | 2.94649425 |
104 | valine metabolic process (GO:0006573) | 2.94606370 |
105 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.94083985 |
106 | fibrinolysis (GO:0042730) | 2.92449075 |
107 | carnitine transmembrane transport (GO:1902603) | 2.92132199 |
108 | amino-acid betaine transport (GO:0015838) | 2.92071330 |
109 | carnitine transport (GO:0015879) | 2.92071330 |
110 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.91261985 |
111 | hemidesmosome assembly (GO:0031581) | 2.90898503 |
112 | desmosome organization (GO:0002934) | 2.89606322 |
113 | negative regulation of cell killing (GO:0031342) | 2.89562021 |
114 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.89562021 |
115 | skin morphogenesis (GO:0043589) | 2.87163848 |
116 | drug transmembrane transport (GO:0006855) | 2.86850990 |
117 | alpha-amino acid catabolic process (GO:1901606) | 2.86105704 |
118 | aromatic amino acid family metabolic process (GO:0009072) | 2.85919116 |
119 | cell-substrate junction assembly (GO:0007044) | 2.85178997 |
120 | negative regulation of protein localization to plasma membrane (GO:1903077) | 2.85044413 |
121 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.83366649 |
122 | ketone body metabolic process (GO:1902224) | 2.83166795 |
123 | positive regulation of fatty acid metabolic process (GO:0045923) | 2.82751677 |
124 | macrophage activation involved in immune response (GO:0002281) | 2.79992135 |
125 | pinocytosis (GO:0006907) | 2.79988325 |
126 | response to peptidoglycan (GO:0032494) | 2.79155495 |
127 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.77773061 |
128 | positive regulation of receptor recycling (GO:0001921) | 2.77641680 |
129 | Golgi transport vesicle coating (GO:0048200) | 2.76632428 |
130 | COPI coating of Golgi vesicle (GO:0048205) | 2.76632428 |
131 | detection of molecule of bacterial origin (GO:0032490) | 2.75790936 |
132 | detection of other organism (GO:0098543) | 2.72747708 |
133 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.67928018 |
134 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.65588939 |
135 | negative regulation of interleukin-12 production (GO:0032695) | 2.63630683 |
136 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.63016381 |
137 | cell adhesion mediated by integrin (GO:0033627) | 2.61413197 |
138 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.59101783 |
139 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.57264937 |
140 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.55984029 |
141 | germinal center formation (GO:0002467) | 2.55763661 |
142 | membrane raft organization (GO:0031579) | 2.54630869 |
143 | neutrophil activation involved in immune response (GO:0002283) | 2.54609566 |
144 | detection of external biotic stimulus (GO:0098581) | 2.53446869 |
145 | regulation of early endosome to late endosome transport (GO:2000641) | 2.49816832 |
146 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.49754606 |
147 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.49057931 |
148 | detection of bacterium (GO:0016045) | 2.48270283 |
149 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.45347312 |
150 | positive regulation of extracellular matrix organization (GO:1903055) | 2.44028425 |
151 | response to laminar fluid shear stress (GO:0034616) | 2.41801089 |
152 | cellular extravasation (GO:0045123) | 2.41193731 |
153 | focal adhesion assembly (GO:0048041) | 2.41033311 |
154 | cell-substrate adherens junction assembly (GO:0007045) | 2.41033311 |
155 | glycosphingolipid catabolic process (GO:0046479) | 2.40571225 |
156 | endodermal cell differentiation (GO:0035987) | 2.40498908 |
157 | regulation of extracellular matrix disassembly (GO:0010715) | 2.38464750 |
158 | mannose metabolic process (GO:0006013) | 2.38322618 |
159 | regulation of necroptotic process (GO:0060544) | 2.36997880 |
160 | leukocyte aggregation (GO:0070486) | 2.35574300 |
161 | iron ion import (GO:0097286) | 2.35433109 |
162 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.33110953 |
163 | negative regulation of establishment of protein localization to plasma membrane (GO:0090005) | 2.33033618 |
164 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.32595328 |
165 | regulation of macrophage cytokine production (GO:0010935) | 2.32376385 |
166 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.30352409 |
167 | apoptotic cell clearance (GO:0043277) | 2.29771630 |
168 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 2.29178700 |
169 | embryonic process involved in female pregnancy (GO:0060136) | 2.27338497 |
170 | negative regulation of fatty acid transport (GO:2000192) | 2.26455051 |
171 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.25648514 |
172 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.24746412 |
173 | epithelial cell-cell adhesion (GO:0090136) | 2.23150587 |
174 | adherens junction assembly (GO:0034333) | 2.22555192 |
175 | regulation of gamma-delta T cell activation (GO:0046643) | 2.22161580 |
176 | cellular response to epinephrine stimulus (GO:0071872) | 2.21798766 |
177 | regulation of water loss via skin (GO:0033561) | 2.20864701 |
178 | response to muramyl dipeptide (GO:0032495) | 2.20203730 |
179 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.19964168 |
180 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.19520754 |
181 | response to vitamin D (GO:0033280) | 2.18738454 |
182 | regulation of leukocyte degranulation (GO:0043300) | 2.17963084 |
183 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.17545247 |
184 | glycolipid catabolic process (GO:0019377) | 2.16994321 |
185 | cortical actin cytoskeleton organization (GO:0030866) | 2.16097977 |
186 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.14237714 |
187 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.11463180 |
188 | response to host (GO:0075136) | 2.11463180 |
189 | response to host defenses (GO:0052200) | 2.11463180 |
190 | mammary gland epithelial cell proliferation (GO:0033598) | 2.10991338 |
191 | detection of biotic stimulus (GO:0009595) | 2.10460087 |
192 | muscle filament sliding (GO:0030049) | 2.08047620 |
193 | actin-myosin filament sliding (GO:0033275) | 2.08047620 |
194 | modulation by symbiont of host cellular process (GO:0044068) | 2.07818688 |
195 | membrane protein ectodomain proteolysis (GO:0006509) | 2.06770939 |
196 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.04892880 |
197 | positive regulation of leukocyte degranulation (GO:0043302) | 2.02262633 |
198 | basement membrane organization (GO:0071711) | 2.01585529 |
199 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.01447059 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 7.80776957 |
2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 5.57955558 |
3 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.21590002 |
4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.04878994 |
5 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.66969864 |
6 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.76112806 |
7 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.34514912 |
8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.94005895 |
9 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.92609066 |
10 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.70282345 |
11 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.49571630 |
12 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.26103401 |
13 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.19449355 |
14 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.16768717 |
15 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.12449211 |
16 | GATA1_22025678_ChIP-Seq_K562_Human | 2.10926507 |
17 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.01870838 |
18 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.98735329 |
19 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.98728269 |
20 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.94295665 |
21 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.83217164 |
22 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.78341955 |
23 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.78011293 |
24 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.75681760 |
25 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.75241267 |
26 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.74914784 |
27 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.74032324 |
28 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.66028267 |
29 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.65133477 |
30 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.64447843 |
31 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.63948281 |
32 | SPI1_23127762_ChIP-Seq_K562_Human | 1.63381855 |
33 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.62155443 |
34 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.61522263 |
35 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.60633597 |
36 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.60388883 |
37 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.58660951 |
38 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.57264077 |
39 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.55833437 |
40 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.53144796 |
41 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.51372131 |
42 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.51197237 |
43 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.50298680 |
44 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.49111780 |
45 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.48854349 |
46 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.48272661 |
47 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.47216029 |
48 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.45585854 |
49 | MYC_22102868_ChIP-Seq_BL_Human | 1.45499241 |
50 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.45139321 |
51 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.44711835 |
52 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.44152712 |
53 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.43297493 |
54 | GATA1_19941826_ChIP-Seq_K562_Human | 1.41601019 |
55 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.41536786 |
56 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.40103766 |
57 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.39703719 |
58 | MAF_26560356_Chip-Seq_TH1_Human | 1.38684084 |
59 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.38650107 |
60 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.38233760 |
61 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.36646091 |
62 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.32141461 |
63 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.30646883 |
64 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.29343085 |
65 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.29103275 |
66 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.29010311 |
67 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.25503241 |
68 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.25503241 |
69 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.24895370 |
70 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.23632234 |
71 | GATA2_19941826_ChIP-Seq_K562_Human | 1.21064899 |
72 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.18661224 |
73 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.18380582 |
74 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.17976588 |
75 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.16936034 |
76 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.16677879 |
77 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.15344800 |
78 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.15256500 |
79 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.15002415 |
80 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.13742324 |
81 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.12685342 |
82 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.12461357 |
83 | * ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.12399656 |
84 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.11453963 |
85 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.09059424 |
86 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.08809586 |
87 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.07206409 |
88 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.06357731 |
89 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.04607045 |
90 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.04607045 |
91 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.04521521 |
92 | CJUN_26792858_Chip-Seq_BT549_Human | 1.03091840 |
93 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.02969876 |
94 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.02145086 |
95 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.01566676 |
96 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.01405098 |
97 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.01193395 |
98 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.01188241 |
99 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.00813561 |
100 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.00679872 |
101 | KDM2B_26808549_Chip-Seq_K562_Human | 1.00275276 |
102 | UTX_26944678_Chip-Seq_JUKART_Human | 1.00217166 |
103 | * RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.99551141 |
104 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.98941337 |
105 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.91959675 |
106 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.91867125 |
107 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.91841492 |
108 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.90336902 |
109 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.90170197 |
110 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.89347438 |
111 | ATF3_27146783_Chip-Seq_COLON_Human | 0.89106715 |
112 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.88246724 |
113 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.88225518 |
114 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.88028126 |
115 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.87535651 |
116 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.87247439 |
117 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.87128743 |
118 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.86686796 |
119 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.86402163 |
120 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.85012288 |
121 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.82078172 |
122 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.82059598 |
123 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.79318510 |
124 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.79187318 |
125 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.78971349 |
126 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.78123115 |
127 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.76735872 |
128 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.76735872 |
129 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.75892714 |
130 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.75780237 |
131 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.74233789 |
132 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.73667226 |
133 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.73624393 |
134 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.73461432 |
135 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.71948983 |
136 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.71709171 |
137 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.69714250 |
138 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.68078711 |
139 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.67533501 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0005360_urolithiasis | 5.66881864 |
2 | MP0002139_abnormal_hepatobiliary_system | 5.34434797 |
3 | MP0005085_abnormal_gallbladder_physiolo | 3.98276581 |
4 | MP0005365_abnormal_bile_salt | 3.90081478 |
5 | MP0009840_abnormal_foam_cell | 3.35068051 |
6 | MP0008875_abnormal_xenobiotic_pharmacok | 3.23576356 |
7 | MP0010329_abnormal_lipoprotein_level | 2.85009803 |
8 | MP0003252_abnormal_bile_duct | 2.83656433 |
9 | MP0004510_myositis | 2.73299455 |
10 | MP0003806_abnormal_nucleotide_metabolis | 2.63602163 |
11 | MP0003191_abnormal_cellular_cholesterol | 2.40773369 |
12 | MP0003705_abnormal_hypodermis_morpholog | 2.37825827 |
13 | MP0005083_abnormal_biliary_tract | 2.32668840 |
14 | MP0001666_abnormal_nutrient_absorption | 2.26849776 |
15 | MP0004130_abnormal_muscle_cell | 2.17451045 |
16 | MP0005332_abnormal_amino_acid | 1.95597359 |
17 | MP0003646_muscle_fatigue | 1.94212264 |
18 | MP0003656_abnormal_erythrocyte_physiolo | 1.92244364 |
19 | MP0003195_calcinosis | 1.91188065 |
20 | MP0002118_abnormal_lipid_homeostasis | 1.87811292 |
21 | MP0010234_abnormal_vibrissa_follicle | 1.87736882 |
22 | MP0000609_abnormal_liver_physiology | 1.85869302 |
23 | MP0003828_pulmonary_edema | 1.83270415 |
24 | MP0003091_abnormal_cell_migration | 1.77521203 |
25 | MP0003279_aneurysm | 1.73115068 |
26 | MP0002837_dystrophic_cardiac_calcinosis | 1.70228329 |
27 | MP0008438_abnormal_cutaneous_collagen | 1.65863520 |
28 | MP0008260_abnormal_autophagy | 1.65456250 |
29 | MP0002796_impaired_skin_barrier | 1.61619836 |
30 | MP0005058_abnormal_lysosome_morphology | 1.61172072 |
31 | MP0001835_abnormal_antigen_presentation | 1.60565859 |
32 | MP0004185_abnormal_adipocyte_glucose | 1.56130963 |
33 | MP0004233_abnormal_muscle_weight | 1.56076517 |
34 | MP0003172_abnormal_lysosome_physiology | 1.55673715 |
35 | MP0003453_abnormal_keratinocyte_physiol | 1.54063296 |
36 | MP0003950_abnormal_plasma_membrane | 1.53462238 |
37 | MP0010352_gastrointestinal_tract_polyps | 1.53307944 |
38 | MP0004019_abnormal_vitamin_homeostasis | 1.52008359 |
39 | MP0000858_altered_metastatic_potential | 1.49417438 |
40 | MP0005319_abnormal_enzyme/_coenzyme | 1.48696913 |
41 | MP0005451_abnormal_body_composition | 1.45031454 |
42 | MP0002138_abnormal_hepatobiliary_system | 1.44249157 |
43 | MP0002998_abnormal_bone_remodeling | 1.41415595 |
44 | MP0001851_eye_inflammation | 1.38973483 |
45 | MP0005666_abnormal_adipose_tissue | 1.38512854 |
46 | MP0005409_darkened_coat_color | 1.37670622 |
47 | MP0004084_abnormal_cardiac_muscle | 1.31732020 |
48 | MP0000685_abnormal_immune_system | 1.29747419 |
49 | MP0002971_abnormal_brown_adipose | 1.28889115 |
50 | MP0005025_abnormal_response_to | 1.27896663 |
51 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.27890403 |
52 | MP0009785_altered_susceptibility_to | 1.27816848 |
53 | MP0003303_peritoneal_inflammation | 1.26280183 |
54 | MP0009643_abnormal_urine_homeostasis | 1.25446512 |
55 | MP0004272_abnormal_basement_membrane | 1.24957716 |
56 | MP0005000_abnormal_immune_tolerance | 1.24782817 |
57 | MP0005387_immune_system_phenotype | 1.22268087 |
58 | MP0001790_abnormal_immune_system | 1.22268087 |
59 | MP0004147_increased_porphyrin_level | 1.21627864 |
60 | MP0004036_abnormal_muscle_relaxation | 1.21160568 |
61 | MP0003436_decreased_susceptibility_to | 1.20615726 |
62 | MP0000343_altered_response_to | 1.20302657 |
63 | MP0002148_abnormal_hypersensitivity_rea | 1.18947758 |
64 | MP0010155_abnormal_intestine_physiology | 1.16371615 |
65 | MP0000751_myopathy | 1.15689154 |
66 | MP0010368_abnormal_lymphatic_system | 1.14025960 |
67 | MP0001873_stomach_inflammation | 1.13834024 |
68 | MP0000749_muscle_degeneration | 1.13176801 |
69 | MP0001849_ear_inflammation | 1.11005692 |
70 | MP0005330_cardiomyopathy | 1.10836907 |
71 | MP0005670_abnormal_white_adipose | 1.10089516 |
72 | MP0003448_altered_tumor_morphology | 1.09693418 |
73 | MP0002452_abnormal_antigen_presenting | 1.08800089 |
74 | MP0004087_abnormal_muscle_fiber | 1.07012305 |
75 | MP0005076_abnormal_cell_differentiation | 1.06858186 |
76 | MP0000604_amyloidosis | 1.05284493 |
77 | MP0002933_joint_inflammation | 1.04817198 |
78 | MP0003566_abnormal_cell_adhesion | 1.04126751 |
79 | MP0001800_abnormal_humoral_immune | 1.04031069 |
80 | MP0009764_decreased_sensitivity_to | 1.02229812 |
81 | MP0004883_abnormal_blood_vessel | 1.01334899 |
82 | MP0002332_abnormal_exercise_endurance | 1.01107552 |
83 | MP0005165_increased_susceptibility_to | 1.00970452 |
84 | MP0000598_abnormal_liver_morphology | 1.00945124 |
85 | MP0002896_abnormal_bone_mineralization | 1.00587260 |
86 | MP0002723_abnormal_immune_serum | 1.00442925 |
87 | MP0003763_abnormal_thymus_physiology | 0.99777781 |
88 | MP0003075_altered_response_to | 0.98691530 |
89 | MP0003690_abnormal_glial_cell | 0.98669776 |
90 | MP0009780_abnormal_chondrocyte_physiolo | 0.98624858 |
91 | MP0003221_abnormal_cardiomyocyte_apopto | 0.97238330 |
92 | MP0000759_abnormal_skeletal_muscle | 0.95790486 |
93 | MP0001216_abnormal_epidermal_layer | 0.95498418 |
94 | MP0003300_gastrointestinal_ulcer | 0.93862184 |
95 | MP0008469_abnormal_protein_level | 0.93529271 |
96 | MP0002420_abnormal_adaptive_immunity | 0.92862798 |
97 | MP0001819_abnormal_immune_cell | 0.92446545 |
98 | MP0000733_abnormal_muscle_development | 0.91518758 |
99 | MP0005275_abnormal_skin_tensile | 0.91228030 |
100 | MP0001853_heart_inflammation | 0.91063817 |
101 | MP0008775_abnormal_heart_ventricle | 0.90708836 |
102 | MP0002972_abnormal_cardiac_muscle | 0.90410673 |
103 | MP0003183_abnormal_peptide_metabolism | 0.90389844 |
104 | MP0003724_increased_susceptibility_to | 0.90368853 |
105 | MP0001845_abnormal_inflammatory_respons | 0.90173562 |
106 | MP0005501_abnormal_skin_physiology | 0.88318677 |
107 | MP0005464_abnormal_platelet_physiology | 0.87917996 |
108 | MP0001542_abnormal_bone_strength | 0.87223101 |
109 | MP0003045_fibrosis | 0.86881782 |
110 | MP0002405_respiratory_system_inflammati | 0.86854036 |
111 | MP0001915_intracranial_hemorrhage | 0.86822679 |
112 | MP0004858_abnormal_nervous_system | 0.86425197 |
113 | MP0001544_abnormal_cardiovascular_syste | 0.85886459 |
114 | MP0005385_cardiovascular_system_phenoty | 0.85886459 |
115 | MP0009763_increased_sensitivity_to | 0.85750408 |
116 | MP0003868_abnormal_feces_composition | 0.85529356 |
117 | MP0001533_abnormal_skeleton_physiology | 0.85273718 |
118 | MP0005167_abnormal_blood-brain_barrier | 0.84952593 |
119 | MP0006036_abnormal_mitochondrial_physio | 0.84823016 |
120 | MP0002254_reproductive_system_inflammat | 0.84776723 |
121 | MP0002269_muscular_atrophy | 0.83826239 |
122 | MP0005390_skeleton_phenotype | 0.83488395 |
123 | MP0005375_adipose_tissue_phenotype | 0.83479025 |
124 | MP0000747_muscle_weakness | 0.83345208 |
125 | MP0005334_abnormal_fat_pad | 0.82386843 |
126 | MP0003186_abnormal_redox_activity | 0.81641498 |
127 | MP0004264_abnormal_extraembryonic_tissu | 0.81507037 |
128 | MP0005620_abnormal_muscle_contractility | 0.81456720 |
129 | MP0003795_abnormal_bone_structure | 0.81424733 |
130 | MP0010630_abnormal_cardiac_muscle | 0.81309340 |
131 | MP0004381_abnormal_hair_follicle | 0.80947421 |
132 | MP0008004_abnormal_stomach_pH | 0.80887250 |
133 | MP0009384_cardiac_valve_regurgitation | 0.80307422 |
134 | MP0001958_emphysema | 0.78706829 |
135 | MP0002419_abnormal_innate_immunity | 0.77917986 |
136 | MP0002877_abnormal_melanocyte_morpholog | 0.77871951 |
137 | MP0000750_abnormal_muscle_regeneration | 0.75722035 |
138 | MP0004782_abnormal_surfactant_physiolog | 0.75194494 |
139 | MP0000249_abnormal_blood_vessel | 0.74922398 |
140 | MP0004947_skin_inflammation | 0.74706261 |
141 | MP0009642_abnormal_blood_homeostasis | 0.73907807 |
142 | MP0006138_congestive_heart_failure | 0.72573334 |
143 | MP0009115_abnormal_fat_cell | 0.71993159 |
144 | MP0005636_abnormal_mineral_homeostasis | 0.71673628 |
145 | MP0002078_abnormal_glucose_homeostasis | 0.71603692 |
146 | MP0005023_abnormal_wound_healing | 0.69631941 |
147 | MP0001756_abnormal_urination | 0.68773372 |
148 | MP0009697_abnormal_copulation | 0.68097495 |
149 | MP0006054_spinal_hemorrhage | 0.68044073 |
150 | MP0006082_CNS_inflammation | 0.67366481 |
151 | MP0005408_hypopigmentation | 0.66940602 |
152 | MP0005164_abnormal_response_to | 0.66154396 |
153 | MP0002136_abnormal_kidney_physiology | 0.64597036 |
154 | MP0005535_abnormal_body_temperature | 0.62494756 |
155 | MP0000767_abnormal_smooth_muscle | 0.62377556 |
156 | MP0002060_abnormal_skin_morphology | 0.62240829 |
157 | MP0005376_homeostasis/metabolism_phenot | 0.60321010 |
158 | MP0003011_delayed_dark_adaptation | 0.60039391 |
159 | MP0001764_abnormal_homeostasis | 0.59627400 |
160 | MP0005448_abnormal_energy_balance | 0.59193154 |
161 | MP0002106_abnormal_muscle_physiology | 0.58436497 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Xanthomatosis (HP:0000991) | 4.89082320 |
2 | Deep venous thrombosis (HP:0002625) | 4.82609170 |
3 | Intrahepatic cholestasis (HP:0001406) | 4.36613607 |
4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.93506651 |
5 | Hyperlipoproteinemia (HP:0010980) | 3.80178233 |
6 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.77001039 |
7 | Hypobetalipoproteinemia (HP:0003563) | 3.75195308 |
8 | Complement deficiency (HP:0004431) | 3.68014702 |
9 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.63939420 |
10 | Hypoglycemic coma (HP:0001325) | 3.59187141 |
11 | Hypoalphalipoproteinemia (HP:0003233) | 3.44912404 |
12 | Hypolipoproteinemia (HP:0010981) | 3.42516848 |
13 | Hyperammonemia (HP:0001987) | 3.41778192 |
14 | Epidermoid cyst (HP:0200040) | 3.34795240 |
15 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.32818720 |
16 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.21837290 |
17 | Premature rupture of membranes (HP:0001788) | 3.20819712 |
18 | Distal lower limb muscle weakness (HP:0009053) | 3.18597994 |
19 | Ketosis (HP:0001946) | 3.17256350 |
20 | Hyperglycinuria (HP:0003108) | 3.16787250 |
21 | Eczematoid dermatitis (HP:0000976) | 3.16426566 |
22 | Abnormality of the common coagulation pathway (HP:0010990) | 3.10709944 |
23 | Myocardial infarction (HP:0001658) | 3.10004743 |
24 | Protrusio acetabuli (HP:0003179) | 3.09872829 |
25 | Joint hemorrhage (HP:0005261) | 3.07910395 |
26 | Hypercholesterolemia (HP:0003124) | 3.04684587 |
27 | Round ear (HP:0100830) | 3.04049364 |
28 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.01255872 |
29 | Abnormality of glycine metabolism (HP:0010895) | 3.01255872 |
30 | Prolonged partial thromboplastin time (HP:0003645) | 3.00791942 |
31 | Polycythemia (HP:0001901) | 2.98875602 |
32 | Exercise-induced muscle cramps (HP:0003710) | 2.87898522 |
33 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.77869933 |
34 | Myoglobinuria (HP:0002913) | 2.77822910 |
35 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.77730656 |
36 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.77332832 |
37 | Abnormality of complement system (HP:0005339) | 2.76228821 |
38 | Hydroxyprolinuria (HP:0003080) | 2.73752085 |
39 | Abnormality of proline metabolism (HP:0010907) | 2.73752085 |
40 | Acanthocytosis (HP:0001927) | 2.71751116 |
41 | Increased variability in muscle fiber diameter (HP:0003557) | 2.71710029 |
42 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.70788312 |
43 | Abnormality of glycolipid metabolism (HP:0010969) | 2.68850288 |
44 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.68850288 |
45 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.68850288 |
46 | Nemaline bodies (HP:0003798) | 2.68264808 |
47 | Systemic lupus erythematosus (HP:0002725) | 2.67251128 |
48 | Fat malabsorption (HP:0002630) | 2.67077748 |
49 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.66105196 |
50 | Ketoacidosis (HP:0001993) | 2.65926792 |
51 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.65820114 |
52 | Nausea (HP:0002018) | 2.65632481 |
53 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.65049100 |
54 | Osteolytic defects of the hand bones (HP:0009699) | 2.65049100 |
55 | Skin nodule (HP:0200036) | 2.63430959 |
56 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.62829497 |
57 | Muscle fiber inclusion bodies (HP:0100299) | 2.62027230 |
58 | Right ventricular cardiomyopathy (HP:0011663) | 2.61627163 |
59 | Hyperglycinemia (HP:0002154) | 2.60548741 |
60 | Distal lower limb amyotrophy (HP:0008944) | 2.54412170 |
61 | Abnormality of macrophages (HP:0004311) | 2.53814586 |
62 | Asymmetric septal hypertrophy (HP:0001670) | 2.49252738 |
63 | Hyporeflexia of lower limbs (HP:0002600) | 2.49086877 |
64 | Vascular tortuosity (HP:0004948) | 2.48776151 |
65 | Exercise-induced myalgia (HP:0003738) | 2.48668382 |
66 | Arterial tortuosity (HP:0005116) | 2.46815101 |
67 | Abnormality of purine metabolism (HP:0004352) | 2.45541055 |
68 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.45358769 |
69 | Dicarboxylic aciduria (HP:0003215) | 2.45358769 |
70 | Recurrent abscess formation (HP:0002722) | 2.44310340 |
71 | Abnormality of the intrinsic pathway (HP:0010989) | 2.42513781 |
72 | Poikilocytosis (HP:0004447) | 2.42399090 |
73 | Muscle fiber splitting (HP:0003555) | 2.41883954 |
74 | Axonal loss (HP:0003447) | 2.40556143 |
75 | Hyperbilirubinemia (HP:0002904) | 2.40255522 |
76 | Hepatocellular carcinoma (HP:0001402) | 2.39920501 |
77 | Increased connective tissue (HP:0009025) | 2.38391864 |
78 | Rhabdomyolysis (HP:0003201) | 2.38073182 |
79 | Abnormal cartilage morphology (HP:0002763) | 2.36387986 |
80 | Cholelithiasis (HP:0001081) | 2.35627340 |
81 | Spinal rigidity (HP:0003306) | 2.30165106 |
82 | Vertebral compression fractures (HP:0002953) | 2.29769468 |
83 | Aortic aneurysm (HP:0004942) | 2.28651225 |
84 | Abnormal gallbladder morphology (HP:0012437) | 2.28010497 |
85 | Dysostosis multiplex (HP:0000943) | 2.26329196 |
86 | Gingivitis (HP:0000230) | 2.26315693 |
87 | Generalized aminoaciduria (HP:0002909) | 2.25242690 |
88 | Atrophic scars (HP:0001075) | 2.23736908 |
89 | Thin bony cortex (HP:0002753) | 2.23730982 |
90 | Spondylolisthesis (HP:0003302) | 2.23171959 |
91 | Abnormality of nucleobase metabolism (HP:0010932) | 2.22387794 |
92 | Striae distensae (HP:0001065) | 2.21100193 |
93 | Aortic dissection (HP:0002647) | 2.20096780 |
94 | Metabolic acidosis (HP:0001942) | 2.20093842 |
95 | Ventricular tachycardia (HP:0004756) | 2.17217878 |
96 | Spontaneous hematomas (HP:0007420) | 2.16557632 |
97 | Esophageal varix (HP:0002040) | 2.16174493 |
98 | Dilatation of the ascending aorta (HP:0005111) | 2.14418004 |
99 | Abnormality of methionine metabolism (HP:0010901) | 2.14077245 |
100 | Glomerulonephritis (HP:0000099) | 2.12818398 |
101 | Peritonitis (HP:0002586) | 2.12594302 |
102 | Reticulocytosis (HP:0001923) | 2.12005957 |
103 | Sensorimotor neuropathy (HP:0007141) | 2.11794115 |
104 | Cerebral aneurysm (HP:0004944) | 2.11553822 |
105 | Abnormality of iron homeostasis (HP:0011031) | 2.10768136 |
106 | Gout (HP:0001997) | 2.10501947 |
107 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.06332698 |
108 | Recurrent bacterial skin infections (HP:0005406) | 2.06331326 |
109 | Slender build (HP:0001533) | 2.04455943 |
110 | Aneurysm (HP:0002617) | 2.02981147 |
111 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.02702306 |
112 | Mucopolysacchariduria (HP:0008155) | 2.02410311 |
113 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.02410311 |
114 | Vascular calcification (HP:0004934) | 2.02260493 |
115 | Cardiovascular calcification (HP:0011915) | 2.01454989 |
116 | Fragile skin (HP:0001030) | 2.00312159 |
117 | Hemorrhage of the eye (HP:0011885) | 1.96820459 |
118 | Increased IgE level (HP:0003212) | 1.95792840 |
119 | Cervical subluxation (HP:0003308) | 1.95410981 |
120 | Conjugated hyperbilirubinemia (HP:0002908) | 1.94918219 |
121 | Difficulty running (HP:0009046) | 1.94018047 |
122 | Mitral stenosis (HP:0001718) | 1.93005963 |
123 | Hyperglycemia (HP:0003074) | 1.92531546 |
124 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.89994844 |
125 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.89994844 |
126 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.89994844 |
127 | Increased serum ferritin (HP:0003281) | 1.89571908 |
128 | Thick nail (HP:0001805) | 1.89456535 |
129 | Amyloidosis (HP:0011034) | 1.88905528 |
130 | Sudden death (HP:0001699) | 1.87972771 |
131 | EMG: myopathic abnormalities (HP:0003458) | 1.86456157 |
132 | Nephritis (HP:0000123) | 1.85838104 |
133 | Abnormality of serum amino acid levels (HP:0003112) | 1.85668007 |
134 | Protuberant abdomen (HP:0001538) | 1.85436381 |
135 | Abnormality of the gallbladder (HP:0005264) | 1.84693324 |
136 | Difficulty climbing stairs (HP:0003551) | 1.84592498 |
137 | * Cupped ribs (HP:0000887) | 1.81571193 |
138 | Flat acetabular roof (HP:0003180) | 1.80364383 |
139 | Steatorrhea (HP:0002570) | 1.79218428 |
140 | Achilles tendon contracture (HP:0001771) | 1.78636815 |
141 | Late onset (HP:0003584) | 1.78418796 |
142 | Autoimmune thrombocytopenia (HP:0001973) | 1.77906060 |
143 | Cellulitis (HP:0100658) | 1.77845284 |
144 | Type 1 muscle fiber predominance (HP:0003803) | 1.77246516 |
145 | Wormian bones (HP:0002645) | 1.77133568 |
146 | Ulnar deviation of the wrist (HP:0003049) | 1.76592556 |
147 | Pancreatitis (HP:0001733) | 1.76585123 |
148 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.76081272 |
149 | Lipoatrophy (HP:0100578) | 1.75222690 |
150 | Malnutrition (HP:0004395) | 1.74172220 |
151 | Vacuolated lymphocytes (HP:0001922) | 1.74112846 |
152 | Increased cerebral lipofuscin (HP:0011813) | 1.72811691 |
153 | Thrombophlebitis (HP:0004418) | 1.72469647 |
154 | Neck muscle weakness (HP:0000467) | 1.72089244 |
155 | Abnormal tarsal ossification (HP:0008369) | 1.71532884 |
156 | Interstitial pulmonary disease (HP:0006530) | 1.71444026 |
157 | Increased mean platelet volume (HP:0011877) | 1.71064106 |
158 | Blue sclerae (HP:0000592) | 1.70676946 |
159 | Loss of speech (HP:0002371) | 1.67966948 |
160 | Abnormality of nail color (HP:0100643) | 1.66871663 |
161 | Hematochezia (HP:0002573) | 1.65075777 |
162 | Spinal cord lesions (HP:0100561) | 1.64546303 |
163 | Syringomyelia (HP:0003396) | 1.64546303 |
164 | Ankle contracture (HP:0006466) | 1.63974809 |
165 | Abnormality of the Achilles tendon (HP:0005109) | 1.63614832 |
166 | Orchitis (HP:0100796) | 1.63560536 |
167 | Bulbar palsy (HP:0001283) | 1.63333604 |
168 | Bladder diverticulum (HP:0000015) | 1.61650509 |
169 | Periodontitis (HP:0000704) | 1.61422023 |
170 | Bundle branch block (HP:0011710) | 1.58265675 |
171 | Bone pain (HP:0002653) | 1.57809124 |
172 | Myositis (HP:0100614) | 1.57356598 |
173 | Lower limb amyotrophy (HP:0007210) | 1.57148142 |
174 | Gingival bleeding (HP:0000225) | 1.56848333 |
175 | Broad face (HP:0000283) | 1.55942378 |
176 | Emphysema (HP:0002097) | 1.54464618 |
177 | Toxemia of pregnancy (HP:0100603) | 1.53565731 |
178 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.53422501 |
179 | Scapular winging (HP:0003691) | 1.52943586 |
180 | Gastrointestinal infarctions (HP:0005244) | 1.52581347 |
Rank | Gene Set | Z-score |
---|---|---|
1 | TAOK3 | 4.04430475 |
2 | TRIB3 | 3.93642179 |
3 | TTN | 3.12172579 |
4 | ERN1 | 3.08387140 |
5 | PKN2 | 2.55254251 |
6 | BCKDK | 2.48930895 |
7 | PRPF4B | 2.48719155 |
8 | TBK1 | 2.25088129 |
9 | EPHB1 | 2.23503450 |
10 | SIK1 | 2.16333538 |
11 | LATS1 | 2.09815159 |
12 | RIPK1 | 1.94043626 |
13 | PDK3 | 1.87375916 |
14 | PDK4 | 1.87375916 |
15 | TYK2 | 1.80348365 |
16 | STK24 | 1.78131905 |
17 | MAP2K3 | 1.75795430 |
18 | PTK6 | 1.74305577 |
19 | FGFR4 | 1.66326135 |
20 | STK3 | 1.62638226 |
21 | OBSCN | 1.62186862 |
22 | NEK9 | 1.60214943 |
23 | MAP3K13 | 1.57928702 |
24 | ZAP70 | 1.57800926 |
25 | BLK | 1.57467263 |
26 | PDK2 | 1.54251132 |
27 | MST1R | 1.53599373 |
28 | KSR2 | 1.49944503 |
29 | RIPK4 | 1.43045344 |
30 | ERBB4 | 1.42523555 |
31 | MAP3K3 | 1.37244771 |
32 | FRK | 1.33207360 |
33 | JAK1 | 1.28439505 |
34 | PIK3CG | 1.28025061 |
35 | MAP4K1 | 1.25981811 |
36 | TESK1 | 1.25863120 |
37 | EPHA2 | 1.24534532 |
38 | CDC42BPA | 1.24312229 |
39 | TGFBR2 | 1.22334199 |
40 | SMG1 | 1.20451795 |
41 | CAMK1D | 1.17680109 |
42 | CDK12 | 1.17468008 |
43 | ABL2 | 1.16902026 |
44 | PIK3CA | 1.16000918 |
45 | FES | 1.15173668 |
46 | PDGFRA | 1.13387040 |
47 | DMPK | 1.11359444 |
48 | MAP3K1 | 1.09474526 |
49 | JAK3 | 1.09200656 |
50 | PRKAA2 | 1.08476644 |
51 | MAP3K2 | 1.07269802 |
52 | LMTK2 | 1.04708878 |
53 | PHKG2 | 1.00686259 |
54 | PHKG1 | 1.00686259 |
55 | TRPM7 | 1.00451264 |
56 | PDPK1 | 0.99379994 |
57 | IRAK4 | 0.97326196 |
58 | LRRK2 | 0.96587099 |
59 | TAOK2 | 0.96253477 |
60 | MOS | 0.94733842 |
61 | TAOK1 | 0.94086338 |
62 | MAPKAPK3 | 0.93084710 |
63 | JAK2 | 0.91848093 |
64 | KIT | 0.91146094 |
65 | PRKD2 | 0.88645155 |
66 | IKBKE | 0.88174863 |
67 | EPHB2 | 0.87249113 |
68 | TIE1 | 0.87019623 |
69 | STK38 | 0.86550472 |
70 | INSRR | 0.85366103 |
71 | BMX | 0.82433256 |
72 | STK10 | 0.82391788 |
73 | MAPK11 | 0.81831860 |
74 | MAP3K5 | 0.81661552 |
75 | CDK6 | 0.80434581 |
76 | PRKAA1 | 0.79992201 |
77 | PDGFRB | 0.77620801 |
78 | MET | 0.76576894 |
79 | MYLK | 0.76018454 |
80 | CSK | 0.75539620 |
81 | FLT3 | 0.75166471 |
82 | SCYL2 | 0.74875956 |
83 | IRAK3 | 0.74505630 |
84 | EPHA3 | 0.73489707 |
85 | FGR | 0.72910913 |
86 | RPS6KA2 | 0.70632478 |
87 | HCK | 0.70612430 |
88 | STK38L | 0.70381230 |
89 | SIK3 | 0.67321450 |
90 | MAP3K14 | 0.66459726 |
91 | GRK6 | 0.66305110 |
92 | STK4 | 0.62763198 |
93 | MAPK7 | 0.62119598 |
94 | CSF1R | 0.61524850 |
95 | PDK1 | 0.61073829 |
96 | ICK | 0.60913138 |
97 | PTK2 | 0.60792801 |
98 | GSK3A | 0.60538781 |
99 | PIM2 | 0.60494553 |
100 | CAMK1G | 0.60340431 |
101 | GRK7 | 0.58930057 |
102 | EEF2K | 0.58358338 |
103 | MAP3K8 | 0.57815090 |
104 | PRKD1 | 0.57692600 |
105 | NME2 | 0.57514934 |
106 | KSR1 | 0.56833955 |
107 | FER | 0.56544032 |
108 | MAP3K10 | 0.55842721 |
109 | TEC | 0.55409870 |
110 | BTK | 0.55107170 |
111 | MAP2K1 | 0.53823906 |
112 | KDR | 0.53370273 |
113 | LIMK1 | 0.53330313 |
114 | WNK4 | 0.52771248 |
115 | RET | 0.52418536 |
116 | MAPKAPK2 | 0.51746005 |
117 | RPS6KL1 | 0.51694838 |
118 | RPS6KC1 | 0.51694838 |
119 | ROCK2 | 0.51083198 |
120 | MAP3K7 | 0.51042307 |
121 | PKN1 | 0.49899293 |
122 | PRKG2 | 0.49896686 |
123 | NEK1 | 0.49729351 |
124 | DYRK1B | 0.49268419 |
125 | MTOR | 0.49139828 |
126 | ILK | 0.49109780 |
127 | IKBKB | 0.48316634 |
128 | ARAF | 0.48164513 |
129 | DDR2 | 0.47693467 |
130 | SYK | 0.47686535 |
131 | RAF1 | 0.47605164 |
132 | PIM1 | 0.47570122 |
133 | RPS6KB2 | 0.47415727 |
134 | SGK3 | 0.47150698 |
135 | MAPK12 | 0.46651110 |
136 | PINK1 | 0.45362086 |
137 | PRKACG | 0.45275994 |
138 | MAP3K6 | 0.42901563 |
139 | LATS2 | 0.41947326 |
140 | MAPK4 | 0.38914535 |
141 | ABL1 | 0.37202679 |
142 | PAK2 | 0.37186270 |
143 | MAP2K4 | 0.36024469 |
144 | IGF1R | 0.34518125 |
145 | FGFR3 | 0.34071564 |
146 | ERBB2 | 0.33937349 |
147 | PAK4 | 0.33672732 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.04472189 |
2 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.95898731 |
3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.79213393 |
4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.75326724 |
5 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.69760235 |
6 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.47952933 |
7 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.39167937 |
8 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.36775262 |
9 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.34194306 |
10 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.33317134 |
11 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.31220736 |
12 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.27305903 |
13 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.21867061 |
14 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.18930652 |
15 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.06523883 |
16 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.96409706 |
17 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.87389214 |
18 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.84524647 |
19 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.78146481 |
20 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.76443746 |
21 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.76260437 |
22 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.76187698 |
23 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.74169137 |
24 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.73919432 |
25 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.73398663 |
26 | Peroxisome_Homo sapiens_hsa04146 | 1.72091750 |
27 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.71733515 |
28 | Histidine metabolism_Homo sapiens_hsa00340 | 1.65092192 |
29 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.59227728 |
30 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.55742925 |
31 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.53886767 |
32 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.52723247 |
33 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.51489418 |
34 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.51081963 |
35 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.50044351 |
36 | Carbon metabolism_Homo sapiens_hsa01200 | 1.49748691 |
37 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.46137411 |
38 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.45726208 |
39 | Bile secretion_Homo sapiens_hsa04976 | 1.44658733 |
40 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.44358728 |
41 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.38361319 |
42 | Bladder cancer_Homo sapiens_hsa05219 | 1.37062257 |
43 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.37024683 |
44 | Tuberculosis_Homo sapiens_hsa05152 | 1.34611541 |
45 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.32276298 |
46 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.30706344 |
47 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.29198332 |
48 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.28135260 |
49 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.27173300 |
50 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.23460439 |
51 | Hepatitis C_Homo sapiens_hsa05160 | 1.23325002 |
52 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.21870320 |
53 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.19453027 |
54 | Endometrial cancer_Homo sapiens_hsa05213 | 1.18666000 |
55 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.18449952 |
56 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.18389899 |
57 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.18281831 |
58 | ABC transporters_Homo sapiens_hsa02010 | 1.16442203 |
59 | Retinol metabolism_Homo sapiens_hsa00830 | 1.14271355 |
60 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.14177602 |
61 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.14019562 |
62 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.13050214 |
63 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.12165878 |
64 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.11485164 |
65 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.11441091 |
66 | Measles_Homo sapiens_hsa05162 | 1.07754253 |
67 | Shigellosis_Homo sapiens_hsa05131 | 1.05868095 |
68 | Influenza A_Homo sapiens_hsa05164 | 1.05662063 |
69 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.04877727 |
70 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.04792117 |
71 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.02288953 |
72 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 1.02081603 |
73 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.01835130 |
74 | Thyroid cancer_Homo sapiens_hsa05216 | 1.01768803 |
75 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.00986232 |
76 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.00952218 |
77 | Platelet activation_Homo sapiens_hsa04611 | 1.00630611 |
78 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.99551914 |
79 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.98301433 |
80 | Hepatitis B_Homo sapiens_hsa05161 | 0.97622492 |
81 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.97112928 |
82 | Lysine degradation_Homo sapiens_hsa00310 | 0.96959642 |
83 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.93644986 |
84 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.92528395 |
85 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.92187257 |
86 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.90095043 |
87 | Prion diseases_Homo sapiens_hsa05020 | 0.89859178 |
88 | Adherens junction_Homo sapiens_hsa04520 | 0.89733071 |
89 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.89619272 |
90 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.89191172 |
91 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.88987406 |
92 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.88653644 |
93 | Glioma_Homo sapiens_hsa05214 | 0.88318870 |
94 | Apoptosis_Homo sapiens_hsa04210 | 0.87426317 |
95 | Insulin resistance_Homo sapiens_hsa04931 | 0.85498983 |
96 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.84968987 |
97 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.83256755 |
98 | Salmonella infection_Homo sapiens_hsa05132 | 0.82866919 |
99 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.82026048 |
100 | Prostate cancer_Homo sapiens_hsa05215 | 0.81271304 |
101 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.80399252 |
102 | Endocytosis_Homo sapiens_hsa04144 | 0.79854119 |
103 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.79245694 |
104 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.79185545 |
105 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.79051148 |
106 | Galactose metabolism_Homo sapiens_hsa00052 | 0.77878063 |
107 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.77579071 |
108 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.76776911 |
109 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.76739602 |
110 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.76621964 |
111 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.76303288 |
112 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.76295233 |
113 | Allograft rejection_Homo sapiens_hsa05330 | 0.75520364 |
114 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.75184284 |
115 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.74086566 |
116 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.74042466 |
117 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.74007525 |
118 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.73492628 |
119 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.71450007 |
120 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.71329385 |
121 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.69406691 |
122 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.63128221 |
123 | Lysosome_Homo sapiens_hsa04142 | 0.61405885 |
124 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.61192946 |
125 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.61028029 |
126 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.60906902 |
127 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.59555741 |
128 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.59214786 |
129 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.58776866 |
130 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.58147331 |
131 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.57831270 |
132 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.57639512 |
133 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.57405515 |
134 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.57182521 |
135 | Colorectal cancer_Homo sapiens_hsa05210 | 0.54802556 |
136 | Mineral absorption_Homo sapiens_hsa04978 | 0.53209251 |
137 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.48095571 |
138 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.46316400 |
139 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.45183251 |
140 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.40146609 |
141 | Amoebiasis_Homo sapiens_hsa05146 | 0.35699010 |
142 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.31858062 |
143 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.31702743 |
144 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.31675232 |
145 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.27224501 |
146 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.27019318 |
147 | Sulfur relay system_Homo sapiens_hsa04122 | 0.26735900 |
148 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.26035519 |
149 | Pertussis_Homo sapiens_hsa05133 | 0.25145054 |
150 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.25061939 |
151 | Other glycan degradation_Homo sapiens_hsa00511 | 0.24512725 |
152 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.24184010 |
153 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.23889421 |
154 | Leishmaniasis_Homo sapiens_hsa05140 | 0.23683658 |
155 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.22750992 |
156 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.21405658 |
157 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.21358637 |
158 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.20522405 |
159 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.20290048 |
160 | Malaria_Homo sapiens_hsa05144 | 0.19389774 |
161 | Focal adhesion_Homo sapiens_hsa04510 | 0.19091550 |
162 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.19024138 |
163 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.18794268 |
164 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.17311531 |
165 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.17303559 |
166 | Viral myocarditis_Homo sapiens_hsa05416 | 0.16910850 |
167 | Phagosome_Homo sapiens_hsa04145 | 0.16780747 |
168 | Legionellosis_Homo sapiens_hsa05134 | 0.16520962 |